Expression of matrix metalloproteinase-9 mRNA and vascular endothelial growth factor protein in gastric carcinoma and its relationship to its pathological features and prognosis

Anatomical Record

Volumn 293, Issue 12, 2010, Pages 2012-2019

  Yang, Qiong ^a   Ye, Zai Yuan ^a   Zhang, Jing Xia ^a   Tao, Hou Quan ^a   Li, Shu Guang ^a   Zhao, Zhong Sheng ^b  

^a Key Laboratory of Gastroenterology of Zhejiang Province   (China)

^b ZHEJIANG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Matrix metalloproteinase 9; Metastasis; Prognosis; Stomach neoplasms; Vascular endothelial growth factor

Indexed keywords

CD34 ANTIGEN; GELATINASE B; MESSENGER RNA; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER INFILTRATION; CANCER INVASION; CANCER PATIENT; CANCER SURVIVAL; CANCER TISSUE; CONTROLLED STUDY; DISEASE SEVERITY; DISTANT METASTASIS; FEMALE; GASTRECTOMY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MICROVASCULARIZATION; OVERALL SURVIVAL; PERITONEUM METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STOMACH CANCER; STOMACH CARCINOGENESIS; STOMACH CARCINOMA; STOMACH MUCOSA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD34; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; GASTRIC MUCOSA; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; REFERENCE VALUES; RNA, MESSENGER; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 78649694615     PISSN: 19328486     EISSN: 19328494     Source Type: Journal    
DOI: 10.1002/ar.21071     Document Type: Article

References (23)

1. Ahn JS, Kim MK, Hahn JH, Park JH, Park KH, Cho BR, Park SB, Kim DJ. 2008. Tissue transglutaminase-induced down-regulation of matrix metalloproteinase -9. Biochem Biophys Res Commun 376: 743-747.
2. Bendeck MP, Irvin C, Reidy M, Smith L, Mulholland D, Horton M, Giachelli CM. 2000. Smooth muscle cell matrix metalloproteinase production is stimulated via alpha(v)beta(3) integrin. Arterioscler Thromb Vasc Biol 20: 1467-1472.
3. Chantrain CF, Shimada H, Jodele S, Groshen S, Ye W, Shalinsky DR, Werb Z, Coussens LM, DeClerck YA. 2004. Stromal matrix metalloproteinase-9 regulates the vascular architecture in neuroblastoma by promoting pericyte recruitment. Cancer Res 64: 1675-1686.
4. Cox G, Jones JL, O'Byrne KJ. 2000. Matrix metalloproteinase 9 and the epidermal growth factor signal pathway in operable non-small cell lung cancer. Clin Cancer Res 6: 2349-2355.
5. Crew KD, Neugut AI. 2006. Epidemiology of gastric cancer. World J Gastroenterol 12: 354-362.
6. Greene FL, Page DL, Fleming ID, Fritz A, Balch CM, Haller DG, Morrow M. 2002. Stomach. In: American Joint Committee on Cancer. AJCC cancer staging manual. 6th ed. New York, NY: Springer. p 99-106.
7. Hawinkels LJ, Zuidwijk K, Verspaget HW, de Jonge-Muller ES, van Duijn W, Ferreira V, Fontijn RD, David G, Hommes DW, Lamers CB, Sier CF. 2008. VEGF release by MMP-9 mediated heparan sulphate cleavage induces colorectal cancer angiogenesis. Eur J Cancer 44: 1904-1913.
8. Heissig B, Hattori K, Dias S, Friedrich M, Ferris B, Hackett NR, Crystal RG, Besmer P, Lyden D, Moore MA, Werb Z, Rafii S. 2002. Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 109: 625-637.
9. Himelstein BP, Lee EJ, Sato H, Seiki M, Muschel RJ. 1997. Transcriptional activation of the matrix metalloproteinase-9 gene in an H-ras and v-myc transformed rat embryo cell line. Oncogene 14: 1995-1998.
10. Hiratsuka S, Nakamura K, Iwai S, Murakami M, Itoh T, Kijima H, Shipley JM, Senior RM, Shibuya M. 2002. MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. Cancer Cell 2: 289-300.
11. Hong S, Park KK, Magae J, Ando K, Lee TS, Kwon TK, Kwak JY, Kim CH, Chang YC. 2005. Ascochlorin inhibits matrix metalloproteinase-9 expression by suppressing activator protein-1-mediated gene expression through the ERK1/2 signaling pathway: inhibitory effects of ascochlorin on the invasion of renal carcinoma cells. J Biol chem 280: 25202-25209.
12. Jeon SH, Chae BC, Kim HA, Seo GY, Seo DW, Chun GT, Kim NS, Yie SW, Byeon WH, Eom SH, Ha KS, Kim YM, Kim PH. 2007. Mechanisms underlying TGF-beta1-induced expression of VEGF and Flk-1 in mouse macrophages and their implications for angiogenesis. J Leukoc Biol 81: 557-566.
13. Kim DS, Jeon OH, Lee HD, Yoo KH, Kim DS. 2008. Integrin alphavbeta3-mediated transcriptional regulation of TIMP-1 in a human ovarian cancer cell line. Biochem Biophys Res Commun 377: 479-483.
14. Kunigal S, Lakka SS, Joseph P, Estes N, Rao JS. 2008. Matrix metalloproteinase-9 inhibition down-regulates radiation-induced nuclear factor-kappa B activity leading to apoptosis in breast tumors. Clin Cancer Res 14: 3617-3626.
15. Lévesque JP, Hendy J, Winkler IG, Takamatsu Y, Simmons PJ. 2003. Granulocyte colony-stimulating factor induces the release in the bone marrow of proteases that cleave c-KIT receptor (CD117) from the surface of hematopoietic progenitor cells. Exp Hematol 31: 109-117.
16. Ma Z, Qin H, Benveniste EN. 2001. Transcriptional suppression of matrix metalloproteinase-9 gene expression by IFN-γ and IFN-beta: critical role of STATS-l alpha. J Immunol 167: 5150-5159.
17. Nagase H, Visse R, Murphy G. 2006. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 69: 562-573.
18. Pei XH, Nakanishi Y, Takayama K, Bai F, Hara N. 1999. Granulocyte, granulocyte-macrophage, and macrophage colony-stimulating factors can stimulate the invasive capacity of human lung cancer cells. Br J Cancer 79: 40-46.
19. Roelle S, Grosse R, Aigner A, Krell HW, Czubayko F, Gudermann T. 2003. Matrix metalloproteinases 2 and 9 mediate epidermal growth factor receptor transactivation by gonadotropin-releasing hormone. J Biol Chem 278: 47307-47318.
20. Simon C, Goepfert H, Boyd D. 1998. Inhibition of the p38 mitogen-activated protein kinase by SB 203580 blocks PMA-induced Mr 92, 000 type IV collagenase secretion and in vitro invasion. Cancer Res 58: 1135-1139.
21. van 't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH. 2002. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415: 530-536.
22. Wu CY, Wu MS, Chiang EP, Chen YJ, Chen CJ, Chi NH, Shih YT, Chen GH, Lin JT. 2007. Plasma matrix metalloproteinase-9 level is better than serum matrix metalloproteinase-9 level to predict gastric cancer evolution. Clin Cancer Res 13: 2054-2060.
23. Xu M, Bruno E, Chao J, Huang S, Finazzi G, Fruchtman SM, Popat U, Prchal JT, Barosi G, Hoffman R; MPD Research Consortium. 2005. Constitutive mobilization of CD34+ cells into the peripheral blood in idiopathic myelofibrosis may be due to the action of a number of proteases. Blood 105: 4508-4515.